Scientific Qualifications :
M.D. Damascus university,Mention :very good-1980
Certification in Heamatology-Ministry of Health-1983
C.E.S. in  Human Biology and Hematology,  University of Paris VII –Saint Louis-1988
D.U. in Clinical Heamatology- University of Paris VII –Saint Louis-1989
D.I.S/D.I.S.C. in Oncology - University of Paris V(Rene Descart)1985-1989
D.U. in Breast Disease and Cancer –university of Paris south-west /Rene-Huegnin Tumor                                          Center1989
CURRENT JOB:
Fabruary2010-todate:   Consultant inHematolog/ Oncology:
Saint Louis Hospital/Dar Al-Shifaa Hospital
 Clinic:13-Al-Hamra St. Damascus
 
 
PREVIOUS JOBS:
Sep.1980-Oct.1983:   Resident in Internal Medicine and Hematology in Al-Mazzeh Hospital
                                       Damascus-SYRIA
Dec1983-Dec 1984:   consultant   in Hematology at Teshreen Hospital-Damascus
Jan1985-sep1985 :    Attachement in  Hematology Department at Saint Louis Hospital –
                                   Paris-FRANCE
Oct1985Jan1986:       Attachement in  Bone Marrow Transplantation Unit at Saint Louis Hospital
                                     Paris-FRANCE
Jan1986-Oct1987:     Attachement in CANCER CENTER at TENON HOSPITAL/Assistance Publique/
                                     Paris-FRANCE
Oct1987-oct1989:  Attachement in INSTITUTE CURIE –Paris –FRANCE
Oct1989-Dec1989 :Attachement in Hematology Department at Saint Louis Hospital –Paris
Jan1990-Oct1991 :Consultant and Deputy Hematology and Chemtherapy Department at
                                    Eshreen Hospital-Damascus
Nov1991-Nov1995:Head of Hematology Department at Teshreen Hospital-Damascus
Dec1995-Jan1997 :Deputy Hematology Department at Teshreen Hospital-Damascus
April 1997 toSep 2008:
Consultant in Medical Oncology and Hematology - AL-Bairuni University Hospital
2008-2010:   Consultant in Oncology: Clinic:13-Al-Hamra St. Damascus
                                  Head of Breast Cancer Unit -  AL-Bairuni University Hospital

Publications
1-Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
2010;8:S-29-S-35 J Natl Compr Canc Netw
Bazarbachi A, Azim HA, Alizadeh H, Aljurf M, Barista I, Chaudhri NA, Fahed Z, Fahmy OA, Ghavamzadeh A, Khalaf MH, Khatib S, Kutoubi A, Paydas S, Elayoubi HR, Zaatari G, Zawam HM, Zelenetz AD; MENA Lymphoma Regional Guidelines Committee.
2-
2-Initial characteristics of ph+ chronic-phase CML (cpCML): A comparison Between Asian and German Patients on the international oncology study group (ISOG) CML-1 Study, and the German CMS Study Group Protocol.
FJ Giles, R Hehlmann, A Hochhaus, Ka Salim, PM Shah, BL Rapoport, V Poovalingam, I Sspandiman, P Tan, R Torres, M Gonzaga,LX Wang, V Kochupillai, YC Chen, GY TEE, Z. Fahed, C Suharti, SH Advani, LL Heng, M Patel, S Chen, R Sumantri, SN Lee,and AL . 26th Congress of the international Society of Hematology (ISH), Singapore, August 25-29, 1996.
3- A Prospective Randomized Trial of Hydroxyurea plus Alpha 2b interferon versus Area-c plus FIN in ph+ CML Patients, The international Oncology Study Group CML 1 Study.
FJ GILES, Ka Salim, v poovalingam, BL Rapoport, I Supandiman, PM Shah, F Rana, M Patel, Z Aziz, P Tan , V Kochupillai, Z Fahed, SH Advani, GY Tee, A Cavilez, M Franco, Fuerst, J Tam, D Kusanco, and SWLim. XIVth Meeting of the International Society of Hematology, European and African Division, Stockholm, Sweden, August 30-Sep4,1997.
4- An Update on the international Oncology Study Group! Study: Hydroxyurea plus alpha 2b
 BL Rapoprt, V Poovalingam, M Patel, Wr Bezwoda, LS Fourie, PJ du Toit, KA Salim, PM Shah, P Tan, F Rana, Z Fahed, SW Lim, MP Fuerst, JT Tam, DA, Kusuanco, MM Franco, and FJGiles. Poster presentation at SASMO/SASRO CONGRESS, MARCH.23-26, 1997.

5- The International Oncology Study Group (IOSG) CML 1 Study: presenting features of the Chinese Patient Cohort.
 FJ Giles, LX Wang, S Chen, CC Wang, NB Chang, HF Tien, CH HO, TY Chao, PC Dong, KA Salim, Z Fahed, and AL The First National Congress of Hematology Oncology, May 6-8,1996, Beijing, China.